Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
OTLK compared with KPRX: revenue, margins and what each company keeps, and the suppliers and customers both name
OTLK
Outlook Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
KPRX
Kiora Pharmaceuticals Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
OTLK
Outlook Therapeutics, Inc.
vs
KPRX
Kiora Pharmaceuticals Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
OTLK
Outlook Therapeutics, Inc.
Change
0.46
▼
−6.59%
· post 0.46
Mkt cap
$114.0M
Revenue
$8,700
Q3 FY26
KPRX
Kiora Pharmaceuticals Inc
Change
1.58
▼
−10.50%
· post 1.58
Closed
Oct 30 '26
Mkt cap
$6.9M
Revenue
$20,000
Q2 FY24
vs
Compare
Closed
Oct 30 '26
OTLK
Outlook Therapeutics, Inc.
vs
KPRX
Kiora Pharmaceuticals Inc
0.46
▼
−6.59%
post 0.46
Price
1.58
▼
−10.50%
post 1.58
$114.0M
Mkt cap
$6.9M
Q3 FY26
$8,700
Revenue
$20,000
Q2 FY24
Change
Change
OTLK
0.46
▼
−6.59%
vs
KPRX
1.58
▼
−10.50%
Closed
Oct 30 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
OTLK, solid
KPRX, dashed
Supply-chain overlap
Revenue flow
OTLK: latest quarter is a loss; flow not drawable. KPRX: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only OTLK
1
COR
Cencora
supplier
Shared
0
No shared counterparties.
Only KPRX
1
—
Théa Open Innovation
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR